Novosurge

Hard-tissue Structured Incision System

Health Tech & Life Sciences
Non Active, Jan 2014
Pre-Funding Tel Aviv-Yafo, Israel Founded 2008
Last updated 2026-06-18
Total raised
Last: Grant
Stage
Pre-Funding
Founded
2008
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

NovoSurge is developing a robotic, structured incision system for tailor-made, predefined, and precise hard-tissue incisions, a system that will spare patients unnecessary suffering, reduce complications, and lower M&M rates. Applying ultrasonic incising technology and an ultrasound imaging system, the Structured Sternum Incision (SSI) platform is essentially a robotic-assisted surgery solution for performing a structured, tailor-made, novel, non-linear sternotomy of predetermined pattern anddepth. The SSI platform was engineered to respond tothe shortcomings of existing midline sternotomy techniques. The incision made by the ultrasonic incision technology is of a sinusoidal shape and is adjustable in form and length, resulting in a non-linear edge pattern that provides for a steadier and more accurate mutual positioning of the two sternal halves. The patterned structure of the incision further prevents longitudinal slide and friction of the sternum edges.

Funding history · 1 round · — total

Date unknown
Grant Undisclosed

Q&A

What is Novosurge's primary focus?
Novosurge is developing a robotic, structured incision system for tailor-made, predefined, and precise hard-tissue incisions, aiming to reduce patient suffering, complications, and M&M rates.
What technology does Novosurge's Structured Sternum Incision (SSI) platform utilize?
The SSI platform applies ultrasonic incising technology and an ultrasound imaging system to perform structured, tailor-made, non-linear sternotomies with predetermined patterns and depths.
What problem does Novosurge's SSI platform address?
The SSI platform was engineered to address the shortcomings of existing midline sternotomy techniques, providing a non-linear edge pattern for steadier and more accurate mutual positioning of sternal halves and preventing longitudinal slide and friction.
When was Novosurge founded?
Novosurge was founded in January 2008.
What is the current status of Novosurge?
Novosurge is currently inactive, as of January 2014.
How many employees does Novosurge have?
Novosurge has an employee count in the 1-10 range.
Who are the co-founders of Novosurge?
The co-founders of Novosurge are Ehud Almon, Roni Shafir, and Dan Aravot.
What type of funding has Novosurge received?
Novosurge has received a Grant from the Office of the Chief Scientist.

Team · 3

Ehud Almon
Founder · Co-Founder & CEO
Roni Shafir
Founder · Co-Founder
Dan Aravot
Founder · Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical EquipmentHealthcareProviders
Business model
B2B

Tags

surgeonsmedical-devicesroboticsultrasoundsurgeryimagingassistive-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2008-1
Employees (exact)6
Status reasonNon Active, Jan 2014